tm logo
AVALERE CELL & GENE POLICY 360
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 15 Jan 2024

Last Applicant/ Owned by

1201 New York Avenue NW, Suite 1000

Washington

DC

20005

Serial Number

97270076 filed on 16th Feb 2022

Registration Number

N/A

Correspondent Address

Lynn E. Rzonca

BALLARD SPAHR LLP

1735 MARKET STREET, 51ST FLOOR

PHILADELPHIA PA 19103-7599

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

"CELL & GENE POLICY"

AVALERE CELL & GENE POLICY 360

"CELL & GENE POLICY" Providing a website featuring health policy information in the field of cell and gene therapy AVALERE CELL AND GENE POLICY THREE HUNDRED SIXTY; AVALERE CELL AND GENE POLICY THREE SIX ZERO Providing on-line subscription newsletters featuring news, updates, reports, and analyses of federal policy developments in the field of cell and gene therapy

Classification Information


Class [044]
Medical, Beauty & Agricultural Services


Providing a website featuring health policy information in the field of cell and gene therapy

Class [041]
Education and Entertainment Services


Providing on-line subscription newsletters featuring news, updates, reports, and analyses of federal policy developments in the field of cell and gene therapy

Mark Details


Serial Number

No 97270076

Mark Type

No Service Mark

Attorney Docket Number

No 00402136

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
16th Jan 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
15th Jan 2024ABANDONMENT - NO USE STATEMENT FILED
13th Jun 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
18th Apr 2023PUBLISHED FOR OPPOSITION
18th Apr 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
29th Mar 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12th Mar 2023APPROVED FOR PUB - PRINCIPAL REGISTER
11th Mar 2023TEAS/EMAIL CORRESPONDENCE ENTERED
10th Mar 2023TEAS RESPONSE TO OFFICE ACTION RECEIVED
10th Mar 2023CORRESPONDENCE RECEIVED IN LAW OFFICE